Cargando…
Initial evaluation of PET/CT with (18)F‐FSU‐880 targeting prostate‐specific membrane antigen in prostate cancer patients
This first‐in‐man study was carried out to evaluate the safety, whole‐body distribution, dose estimation, and lesion accumulation of (18)F‐FSU‐880, a newly developed probe targeting prostate‐specific membrane antigen. Six prostate cancer patients with known metastatic lesions underwent serial whole‐...
Autores principales: | Saga, Tsuneo, Nakamoto, Yuji, Ishimori, Takayoshi, Inoue, Takahiro, Shimizu, Yoichi, Kimura, Hiroyuki, Akamatsu, Shusuke, Goto, Takayuki, Watanabe, Hiroyuki, Kitaguchi, Kosuke, Watanabe, Masao, Ono, Masahiro, Saji, Hideo, Ogawa, Osamu, Togashi, Kaori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361557/ https://www.ncbi.nlm.nih.gov/pubmed/30549183 http://dx.doi.org/10.1111/cas.13911 |
Ejemplares similares
-
First-in-Human Evaluation of Positron Emission Tomography/Computed Tomography With [(18)F]FB(ePEG12)12-Exendin-4: A Phase 1 Clinical Study Targeting GLP-1 Receptor Expression Cells in Pancreas
por: Fujimoto, Hiroyuki, et al.
Publicado: (2021) -
Increased [(18)F]FMISO accumulation under hypoxia by multidrug-resistant protein 1 inhibitors
por: Shimizu, Yoichi, et al.
Publicado: (2021) -
Additional information gained by positron emission tomography with (68)Ga-DOTATOC for suspected unknown primary or recurrent neuroendocrine tumors
por: Nakamoto, Yuji, et al.
Publicado: (2015) -
FSU visit to participate in data taking shifts for CMS HCAL
Publicado: (2016) -
Prognostic value of pretreatment FDG PET/CT in uterine cervical cancer according to two major histologic types: squamous cell carcinoma and adenocarcinoma
por: Otani, Tomoaki, et al.
Publicado: (2023)